ZA851046B - Method for directed visceral metabolism of medium chain triglycerides - Google Patents

Method for directed visceral metabolism of medium chain triglycerides

Info

Publication number
ZA851046B
ZA851046B ZA851046A ZA851046A ZA851046B ZA 851046 B ZA851046 B ZA 851046B ZA 851046 A ZA851046 A ZA 851046A ZA 851046 A ZA851046 A ZA 851046A ZA 851046 B ZA851046 B ZA 851046B
Authority
ZA
South Africa
Prior art keywords
chain triglycerides
medium chain
visceral
metabolism
directed
Prior art date
Application number
ZA851046A
Other languages
English (en)
Inventor
Richard Cotter
W Bruce Rowe
Robert C Johnson
Susan K Young
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24339526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA851046(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of ZA851046B publication Critical patent/ZA851046B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA851046A 1984-03-01 1985-02-12 Method for directed visceral metabolism of medium chain triglycerides ZA851046B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/584,974 US4678807A (en) 1984-03-01 1984-03-01 Method for directed visceral metabolism of medium chain triglycerides

Publications (1)

Publication Number Publication Date
ZA851046B true ZA851046B (en) 1985-09-25

Family

ID=24339526

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA851046A ZA851046B (en) 1984-03-01 1985-02-12 Method for directed visceral metabolism of medium chain triglycerides

Country Status (9)

Country Link
US (1) US4678807A (de)
EP (1) EP0172880B2 (de)
JP (1) JP2509810B2 (de)
AT (1) ATE73996T1 (de)
AU (1) AU574438B2 (de)
CA (1) CA1249523A (de)
DE (1) DE3585712D1 (de)
WO (1) WO1985003863A1 (de)
ZA (1) ZA851046B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
US5120306A (en) * 1990-03-21 1992-06-09 Gosselin Leon F Direct delivery of anti-inflammatories to the proximal small bowel
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5622991A (en) * 1994-08-30 1997-04-22 Cornell Research Foundation, Inc. Treating inflammatory liver disorders by enterally administering a fat-containing diet low in polyunsaturated fats
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US6835408B2 (en) 1998-11-13 2004-12-28 The Nisshin Oillio Group, Ltd. Oil or fat composition
DE10130491A1 (de) * 2001-06-25 2003-04-17 Heirler Horst Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
AU2003261928A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Agents, foods and drinks controlling lipid metabolism
WO2004022049A1 (ja) * 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. 痩身剤およびその飲食物
WO2004022051A1 (ja) * 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. ペルオキシソーム増殖薬活性化受容体調整剤
US7915977B2 (en) 2007-09-19 2011-03-29 Isotek Electronics Limited Tuneable bandpass filter
US7659220B1 (en) * 2008-12-03 2010-02-09 Osram Sylvania Inc. Sealing composition for sealing aluminum nitride and aluminum oxynitride ceramics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS537492B2 (de) * 1973-02-12 1978-03-18
US4423072A (en) * 1979-12-28 1983-12-27 The University Of Kentucky Research Foundation Method for improving the metabolic stability and survival of neonatal pigs
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
DE3131460A1 (de) * 1981-08-08 1983-02-24 B. Braun Melsungen Ag, 3508 Melsungen Fettemsulsion fuer parenterale ernaehrung
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
EP0092076B1 (de) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Lipidhaltige Zusammensetzung für die orale, enterale oder parenterale Ernährung
US4528197A (en) * 1983-01-26 1985-07-09 Kabivitrum Ab Controlled triglyceride nutrition for hypercatabolic mammals
WO1985003002A1 (en) * 1984-01-16 1985-07-18 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
AU580278B2 (en) * 1984-01-16 1989-01-12 Baxter International Inc. Treating liver diseases in patients by administering compositions of medium and long chain triglycerides

Also Published As

Publication number Publication date
AU3935485A (en) 1985-09-24
JP2509810B2 (ja) 1996-06-26
EP0172880B1 (de) 1992-03-25
DE3585712D1 (de) 1992-04-30
JPS61501322A (ja) 1986-07-03
EP0172880B2 (de) 1995-11-02
US4678807A (en) 1987-07-07
ATE73996T1 (de) 1992-04-15
AU574438B2 (en) 1988-07-07
WO1985003863A1 (en) 1985-09-12
EP0172880A1 (de) 1986-03-05
CA1249523A (en) 1989-01-31
EP0172880A4 (de) 1987-11-25

Similar Documents

Publication Publication Date Title
ZA851046B (en) Method for directed visceral metabolism of medium chain triglycerides
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
DE68924429D1 (de) Diät zur besserem Ueberleben von Kranken mit Sepsis.
DE3856435D1 (de) Verwendung von Gallsäure-aktiviertem Lipase als Diätsupplement
DK0961552T3 (da) Næringstilskud til pædiatriske patienter
DK413288A (da) Lipid-holdig emulsion til enteral eller parenteral ernaering og farmaceutisk middel indeholdende en saadan emulsion
DE3683337D1 (de) Essbare wasser-in-oel-emulsionen mit einem reduzierten fettgehalt und verwendung dieser emulsionen zur herstellung von baeckereiprodukten.
ES2053497T3 (es) Formulas nutritivas liquidas para la intolerancia a la glucosa.
ES2039004T3 (es) Un procedimiento para preparar una composicion grasa emulsionada.
OA09904A (en) Heat stable oil-in-water emulsion and process for its preparation.
DE3470277D1 (en) Dietetic composition
PT72507B (en) Process for the preparation of 3,4,5-trihydroxypiperidine deri-vatives having effect upon the carbohydrates and lipids metabo-lism and application thereof for the preparation of pharmaceu- tical and/or veterinary compositions having effect upon the carbohydrates and lipids metabolism
ATE58063T1 (de) Verwendung von glycofurol zum verfluessigen von arzneimittelzubereitungen fuer das abfuellen in weichgelatinekapseln.
GR3004533T3 (de)
de la Higuera et al. Influence of dietary composition on gluconeogenesis from L-(U-14C) glutamate in rainbow trout (Salmo gairdneri)
KR910002470A (ko) 혈관 x선 촬영 보조제
ATE209487T1 (de) Verfahren zur behandlung von krebs mittels strukturierten lipiden
NO950621L (no) Fiskefor
DK0380170T4 (da) Lactoproteinfri lav-kalorie smørerstatning med et fedtindhold på 20-60 vægt-% indeholdende gelatine og solubiliseret stivelse
PT89654A (pt) Processo para a preparacao de composicoes que contem gorduras com um baixo conteudo de fosfatidos
DK0465550T3 (da) Farmaceutisk lipidsammensætning til parenteral ernæring
JPS55127318A (en) Emulsifier composition
KR850000973A (ko) 아클라루비신 또는 이의 염산염의 유성 조성물의 제조방법
DE3672387D1 (de) Herstellung von zelladhaesioninhibitoren, so erhaltene antiadhaesine und diese enthaltende arzneimittel und naehrmittel.
Bang et al. Effects of 24-Hour Starvation on the Lipid Content of Carbon Tetrachloride-Induced Fatty Liver in Mice